In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...

X, an internet-based generative AI tool that enables scientists to design protein binders with no coding required. The ...

Pioneering AI Transformation from Bio to Business Intelligence. SEOUL, South Korea, July 22, 2025 /PRNewswire/ -- LG AI Research hosted its "LG AI Talk Concert 2025" today at the ...

Google’s longtime AI guru has quietly backed more than 30 startups in the past two years—offering founders early credibility ...

Google’s GNoME AI might be the most important scientific discovery tool since AlphaFold. By identifying novel, stable ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Latent Labs has launched a web-based AI model, LatentX, aimed at democratizing protein design by enabling novel protein creation directly in users' browsers.

CASP, the protein structure prediction contest that launched DeepMind’s Alphafold to international fame and a Nobel Prize, ...

Quantum computing could revolutionise protein modelling by enabling simulations of molecular behaviour at atomic resolution.

BioEmu, a new deep learning system, predicts protein shapes quickly and accurately, complementing traditional molecular ...

The Department of Biotechnology’s BioE3 policy-short for Biotechnology for Economy, Environment, and Employment is in motion. A national call has been issued for setting up Bio-AI hubs and build new ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...